IFN-γ Is Not Required in the IL-12 Response to Vesicular Stomatitis Virus Infection of the Olfactory Bulb

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3444-3452

  Komatsu, Takashi ^a   Reiss, Carol S ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 12; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; BLOOD; BRAIN LEVEL; C57BL MOUSE; CELL CULTURE; CELL DIVISION; CELL MOTION; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MALE; METABOLISM; MICROGLIA; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; OLFACTORY BULB; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIROLOGY; VIRUS INFECTION;

ANIMALS; ANTIBODIES; ASTROCYTES; BRAIN CHEMISTRY; CELL DIVISION; CELL MOVEMENT; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; NITRIC OXIDE SYNTHASE; OLFACTORY BULB; RHABDOVIRIDAE INFECTIONS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0031255055     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Wagner, R. R. 1987. Rhabdovirus biology and infection: an overview. In The Rhabdovirus. R. R. Wagner, ed. Plenum Press, New York, pp. 9-74.
2. Plakhov, I. V., C. Aoki, E. G. Arlund, and C. S. Reiss. 1995. The earliest events in VSV infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209:257.
3. d system. J. Virol. 65:4950.
4. Huneycutt, B. S., I. V. Plakhov, Z. Shusterman, S. M. Bartido, A. S. Huang, C. S. Reiss, and C. Aoki. 1994. Distribution of vesicular stomatitis virus proteins in the brain of BALB/c mice following intranasal inoculation: an immunohistochemical analysis. Brain Res. 635:81.
5. Lundh, B., K. Kristensson, and E. Norrby. 1987. Selective infection of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses. Neuropathol. Appl. Neurobiol. 13:111.
6. Bi, Z., M. Barna, T. Komatsu, and C. S. Reiss. 1995. a. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:6466.
7. Huneycutt, B. S., Z. Bi, C. J. Aoki, and C. S. Reiss. 1993. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J. Virol. 67:6698.
8. Farrar, M. A., and R. D. Screiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571.
9. Hardy, K. J., and T. Sawada. 1989. Human γ-interferon strongly upregulates its own gene expression in peripheral blood lymphocytes. J. Exp. Med. 170:1021.
10. Chung, I. Y., and E. N. Benveniste. 1990. Tumor necrosis factor-α production by astrocytes. J. Immunol. 144:2999.
11. Donnely, R. P., J. J. Fenton, D. S. Finbloom, and T. L. Gerrard. 1990. Differential regulation of IL-1 production in human monocytes by IFN-γ and IL-4. J. Immunol. 145:569.
12. Collart, M. A., D. Belin, J.-D. Vassalli, S. DeKossodo, and P. Vassalli. 1986. γ-Interferon enhances macrophage transcription of the tumor necrosis factor/ cachectin, interleukin-1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164:2113.
13. Ljungdahl, A., T. Olsson, P. H. Van der Meide, R. Hollmadahl, L. Klareskog, and B. Hojeberg. 1989. Interferon gamma like immunoreactivity in central neurons of the central and peripheral nervous system. J. Neurosci. Res. 24:451.
14. Olsson, T., K. Kristensson, A. Ljungdahl, J. Maehlen, R. Holmdahl, and L. Klareskog. 1989. Gamma-interferon-like immunoreactivity in axtomized rat motor neurons. J. Neurosci. 9:3870.
15. Eneroth, A., K. Kristensson, A. Ljungdahl, and T. Olsson. 1991. Interferon gamma immunoreactivity in developing rat spinal ganglia neurons in vivo and in vitro. J. Neurocytol. 20:225.
16. Kiefer, R., and G. W. Kreutzberg. 1990. Gamma interferon-like immunoreactivity in the rat nervous system. Neuroscience 37:725.
17. Kiefer, R., C. A. Haas, and G. W. Kreutzberg. 1991. Gamma interferon like immunoreactivity in rat neurons: evidence against a close relationship to gamma interferon. Neuroscience 45:551.
18. Kristensson, K., M. Aldskogius, Z. C. Peng, T. Olsson, H. Aldskogius, and M. Bentivoglio. 1994. Co-induction of neuronal interferon-gamma and nitric oxide synthase in rat motor neurons after axotomy: a role in nerve repair or death? J. Neurocytol. 23:453.
19. Olsson, T., S. Kelic, C. Edlund, M. Bakhiet, G. Hojberg, P. H. Van der Meide, A. Ljungdahl, and K. Kristensson. 1994. Neuronal interferon-gamma immunoreactive molecule: bioactivities and purification. Eur. J. Immunol. 24:308.
20. Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, P. M. Guinn, C. M. Dwyer, W. McComas, P. C. Familletti, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148:3433.
21. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dizialo, L. Fritz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Herrmann, S. C. Clark, L. Azzoni, S. H. Chan, G. Trincheiri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Exp. Med. 146:3074.
22. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
23. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon-γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
24. Chehimi, A., N. Valiante, A. D'Andrea, M. Rengaraju, Z. Rosado, M. Kobayashi, B. Perussia, S. F. Wolf, S. E. Starr, and G. Trinchieri. 1993. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur. J. Immunol. 23: 1826.
25. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253.
26. Orange, J. S., T. P. Salazar-Mather, S. M. Opal, R. L. Spencer, A. H. Miller, B. S. McEwen, and C. A. Biron. 1995. Mechanism of interleukin-12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181:901.
27. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer stimulatory factor (interleukin 12) induces T helper type-1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells. J. Exp. Med. 177:1199.
28. Hsieh, C S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of Th1 CD4 T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
29. Wolf, S. F., D. Sieburth, and J. Sypek. 1994. Interleukin-12: a key modulator of immune functions. Stem Cell 12:154.
30. Constantinescu, C. S., K. Frei, U. Malipiero, A. Rostami, and A. Fontana. 1996. Astrocytes and microglial produce IL-12. Ann. NY Acad. Sci. 795:328.
31. Coutelier, J. P., J. V. Broeck, and S. F. Wolf. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1955.
32. Bi, Z., P. Quandt, T. Komatsu, M. Barna, and C. S. Reiss. 1995. b. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J. Immunol. 155:5684.
33. Komatsu, T., M. Barna, and C. S. Reiss. 1997. IL-12 promotes recovery from viral encephalitis. Viral Immunol. 10:35.
34. Komatsu, T., Z. Bi, and C. S. Reiss. 1996. IFN-γ induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:101.
35. Barna, M., T. Komatsu, and C. S. Reiss. 1996. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 223:331.
36. Christian, A. Y., M. Barna, Z. Bi, and C. S. Reiss. 1996. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57B1/6 mice. Viral Immunol. 9:195.
37. Bi, Z., and C. S. Reiss. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208.
38. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, I. Gerecitano, D. Shapiro, J. Le, S. I. Koh, Y. Kimura, S. J. Green, T. W. Mak, T. Taniguchi, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612.
39. Heinzel, F. P., D. S. Shoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
40. Gazzineli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Casper, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533.
41. Sedegah, M., F. Finkelman, and S. L. Hoffman. 1994. Interleukin-12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91:10700.
42. Murray, H. W., and J. Hariprashad. 1995. Interleukin-12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387.
43. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor a are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
44. Muller, U., U. Steinhott, C. F. L. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type-I and type-II interferons in antiviral defense. Science 264:1918.
45. Kundig, T. M., H. Hengartner, and R. M. Zinkernagel. 1993. T cell-dependent IFN-γ exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 150:2316.
46. Fischer, D. G., N. Tal, D. Novick, S. Barak, and M. Rubinstein. 1993. An antiviral soluble form of the LDL Receptor induced by interferon. Science 262:250.
47. Smith, A. L., S. W. Barthold, M. S. de Souza, and K. Bottomly. 1991. The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch. Virol. 121:89.
48. Finke, D., U. G. Brinckmann, V. terMeulen, and U. G. Liebert. 1995. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J. Virol. 69:5469.
49. Rodriguez, M., K. Pavelko, and R. L. Coffman. 1995 Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69:7286.
50. Eneroth, A., T. Andersson, T. Olsson, C. Orvell, E. E. Norrby, and K. Kristensson. 1992. Interferon gamma like immunoreactivity in sensory neurons may influence the replication of Sendai and mumps viruses. J. Neurosci. Res. 31:487.
51. Croen, K. 1993. Evidence for an antiviral effect of nitric oxide. J. Clin. Invest. 91:2446.
52. Karupiah, G., Q. W. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. Macmicking. 1993. Inhibition of viral replication by interferon-γ induced nitric oxide synthase. Science 261:1445.
53. Akarid, K., M. Sinet, B. Desforges, and M. Gougerot-Pocidalo. 1995. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69:7001.
54. Lowenstein, C. J., C. S. Glatt, D. S. Bredt, and S. H. Snyder. 1992. Cloned and expressed macrophage nitric oxide synthase contrast with the brain enzyme. Proc. Natl. Acad. Sci. USA 89:6711.
55. + NK cells. J. Immunol. 148:2429.
56. Gately, M. K., A. G. Wolitzky, P. M. Quinn, and R. Chizzonite. 1992. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 141: 127.
57. Gazzineli, R. T., S. Hieny, T. Wynn, S. Wolf, and A. Sher. 1993. IL-12 is required for T-cell independent induction of IFN-γ by an intracellular parasite and induces resistance in T-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
58. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62:2818.
59. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746.
60. Heinzel, F. P., R. M. Rerko, F. Ahmed, and A. M. Hujer. 1996. IFN-γ-independent production of IL-12 during murine endotoxemia. J. Immunol. 157:4521.